Condition

Acute Myeloid Leukaemia (AML) clinical trials and research

• 6Clinical trials
• 10Countries

Newest Acute Myeloid Leukaemia (AML) clinical trials

All recruiting trials (6)

• Maintenance venetoclax plus subcutaneous cytarabine for fit adults with AML

  This trial will test whether maintenance venetoclax combined with subcutaneous cytarabine helps keep remission longer in fit adults (18–60) with AML who achieved complete remission but cannot get a bone marrow transplant right away.

  Recruiting at 2 sites Sohag University · Sohag and 1 other locations · NCT07244367

• Longitudinal multi-center molecular biomarker registry for blood cancers

  This registry will collect serial blood samples and leftover tissue from people with AML or follicular lymphoma to see if molecular biomarkers predict disease course and treatment outcomes.

  Recruiting at 13 sites Tempus AI · Iowa City, Iowa and 12 other locations · NCT07154823

• Targeting measurable residual AML with tagraxofusp plus azacitidine and venetoclax

  This trial tests whether adding tagraxofusp to azacitidine and venetoclax can safely help control measurable residual acute myeloid leukemia (AML) in adults who are in remission but still have detectable disease.

  Recruiting at 2 sites Phase 1/2 Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT07148180

• Efficacy of HMAs vs Intensive Chemotherapy in AML Guided by 5hmC MRD

  This trial tests whether a blood 5hmC biomarker can guide choosing between hypomethylating agents or intensive chemotherapy for adults with newly diagnosed AML.

  Recruiting Phase 2 The Methodist Hospital Research Institute · Houston, Texas · NCT07060001

• High-dose irradiation followed by immunotherapy for high-risk leukemia patients

  This study is testing a new treatment that combines high-dose radiation with special immune cells to see if it helps patients with high-risk leukemia do better after a stem cell transplant.

  Recruiting University Of Perugia · Perugia, PG · NCT06845592

• L-Annamycin and Cytarabine for treating relapsed AML

  This study is testing if a new combination of L-Annamycin and Cytarabine can help adults with relapsed Acute Myeloid Leukaemia feel better when other treatments haven't worked.

  Recruiting at 28 sites Phase 2/3 Moleculin Biotech, Inc. · Birmingham, Alabama and 27 other locations · NCT06788756

Related topics

Quick answers

How many Acute Myeloid Leukaemia (AML) clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in United States (4 trials), Italy (2 trials), Egypt (1 trial), Czechia (1 trial), Georgia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 2/3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →